Introduction
Materials and methods
Imaging technique
Imaging and analysis procedure
Setting and patient selection
Protocol and data collection
Statistical analysis
Results
Gender: M/F | 21/14 |
Age, median (years) | 65 (56–77) |
APACHE II score, median (IQR) | 20 (14–23) |
SOFA score, median (IQR) | 7 (6–9) |
Use of ventilator | 35 |
PEEP level, median (cmH2O; IQR) | 12 (10–15) |
Continuous venovenous hemofiltration (n) | 2 |
Norepinepherine (n) | 8 |
Median dose, (μg kg−1 min−1;
IQR) | 0.02 (0–0.17) |
Dopamine (n) | 23 |
Median dose (μg kg−1 min−1;
IQR) | 6 (4–10) |
Source of sepsis | |
Abdominal | 28 |
Pneumonia | 7 |
Heart rate, median (beats/min; IQR) | 107 (92–119) |
Mean arterial pressure, median (mmHg; IQR) | 71 (66–81) |
Central venous pressure, median (mmHg; IQR) | 11 (8–14) |
Cardiac index, median (l min−1 m−1;
IQR) | 4.5 (3.5–5.3) |
Central-to-toe temperature difference, median (°C; IQR) | 3.2 (2.2–6) |
Lactate, median (mmol/l; IQR) | 2.5 (1.3–3.4) |
MFI | ΔT | |||
---|---|---|---|---|
r
s
|
p
|
r
s
|
p
| |
Heart rate | 0.12 | 0.50 | 0.03 | 0.85 |
Mean arterial pressure | 0.17 | 0.33 | 0.38 | 0.18 |
Cardiac index | −0.06 | 0.74 | −0.15 | 0.39 |
Central venous pressure | 0.13 | 0.49 | 0.1 | 0.59 |
Norepinepherine dose | 0.17 | 0.34 | 0.04 | 0.82 |
Dopamine dose | 0.10 | 0.58 | 0.10 | 0.58 |
Lactate | −0.17 | 0.37 | 0.1 | 0.59 |
SOFA | 0.18 | 0.29 | −0.08 | 0.64 |
APACHE II | −0.2 | 0.24 | 0.05 | 0.76 |